ARCHIVES

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

“National Clearinghouse” To Guide Selection, Testing, Evaluating Of Suspected Carcinogens

April 9, 1976

CPRIT Awards 32 Grants

November 21, 2014

Men Over Age 75 Shouldn’t Be Screened For Prostate Cancer, Task Force Says

August 29, 2008

Burzynski, Monaco Clashed In Court

June 5, 1992

Constance Percy Retires From NCI After 30 Years.

November 10, 2000

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

April 29, 2011